Tegaserod
Tegaserod is an orally active serotonin receptor 4 (HTR4; 5-HT4R) agonist and a 5-HT2B receptor antagonist. Tegaserod has pKis of 7.5, 8.4 and 7.0 for human recombinant 5-HT2A, 5-HT2B and 5-HT2C receptors, respectively. Tegaserod causes tumor cell apoptosis, blunts PI3K/Akt/mTOR signaling and decreases S6 phosphorylation. Tegaserod has anti-tumor activity and has the potential for irritable bowel syndrome (IBS) research[1][2][3].
Product Specifications
CAS Number
[145158-71-0]
UNSPSC
12352005
Hazard Statement
H317, H410
Target
5-HT Receptor; Apoptosis
Type
Reference compound
Related Pathways
Apoptosis; GPCR/G Protein; Neuronal Signaling
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Cancer; Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/tegaserod.html
Purity
99.89
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
COC1=CC=C(NC=C2/C=N/NC(NCCCCC)=N)C2=C1
Molecular Formula
C16H23N5O
Molecular Weight
301.39
Precautions
H317, H410
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
5-HT2 Receptor; Apolipoprotein D
Citation 01
Int Immunopharmacol. 2025 Sep 23:162:115181.|Nat Commun. 2025 Feb 7;16 (1) :1087.|Mol Med. 2025 Jan 29;31 (1) :30.
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items